Pulmonary Hypertension in Obstructive Sleep Apnea: Is it Clinically Significant? a Critical Analysis of the Association and Pathophysiology
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The development of pulmonary hypertension is a poor prognostic sign in patients with obstructive sleep apnea (OSA) and affects both mortality and quality of life. Although pulmonary hypertension in OSA is traditionally viewed as a result of apneas and intermittent hypoxia during sleep, recent studies indicate that neither of these factors correlates very well with pulmonary artery pressure. Human data show that pulmonary hypertension in the setting of OSA is, in large part, due to left heart dysfunction with either preserved or diminished ejection fraction. Longstanding increased left heart filling pressures eventually lead to pulmonary venous hypertension. The combination of hypoxic pulmonary vasoconstriction and pulmonary venous hypertension with abnormal production of mediators will result in vascular cell proliferation and aberrant vascular remodeling leading to pulmonary hypertension. These changes are in many ways similar to those seen in other forms of pulmonary hypertension and suggest shared mechanisms. The majority of patients with OSA do not receive a diagnosis and are undertreated. Appreciating the high prevalence and understanding the mechanisms of pulmonary hypertension in OSA would lead to better recognition and management of the condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PH related to OSA is generally mild in the absence of additional cardiopulmonary disease, with average mean pulmonary artery pressure between 25 and 30 mm Hg and rarely exceeding 35 mm Hg. 43”
From Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2021) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004
Self-citationThe epidemiology of adult obstructive sleep apnea
Punjabi, N. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200709-155mg · Cited by 2,361 · cited 1×
“An estimated 40 million Americans experience OSA, with a 3%–7% prevalence among men and a 2%–5% prevalence among women.(5) OSA is an independent risk factor for systemic hypertension, stroke, myocardial ischemia, congestive heart failure, arrhythmias, and sudden cardiac death.”
BackgroundGottlieb, D. J., Yenokyan, G., Newman, A. B., O'Connor, G. T., Punjabi, N. M., Quan, S. F., Redline, S., Resnick, H. E., Tong, E. K., Diener-West, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.901801 · Cited by 1,551
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Riociguat for the treatment of pulmonary arterial hypertension
Ghofrani, H.-A., Galiè, N., Grimminger, F., Grünig, E., Humbert, M., Jing, Z.-C., Keogh, A. M., Langleben, D., Kilama, M. O., Fritsch, A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209655 · Cited by 1,346 · cited 8×
“Chronic intermittent hypoxia causes suppression of eNOS and impairment of endothelial-dependent vasodilation by an NF-κB-dependent mechanism.70 In humans with OSA, alveolar NO is reduced.71 Furthermore, circulating cGMP is reduced in patients with OSA with endothelial dysfunction.72 Riociguat, a stimulator of soluble…”
BackgroundInfluentialPulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Ghio, S., Gavazzi, A., Campana, C., Inserra, C., Klersy, C., Sebastiani, R., Arbustini, E., Recusani, F., & Tavazzi, L. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01102-5 · Cited by 1,289
Association of Nocturnal Arrhythmias with Sleep-disordered Breathing
Mehra, R., Benjamin, E. J., Shahar, E., Gottlieb, D. J., Nawabit, R., Kirchner, H. L., Sahadevan, J., & Redline, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1442oc · Cited by 1,262
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Li, J.-M., & Shah, A. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2004 · Cited by 773 · cited 1×
“Superoxide generation in the vascular wall is a well-recognized stimulus for vascular wall cell proliferation and vasoconstriction.(53) These chronic intermittent hypoxia-induced derangements were attenuated in similarly treated gp91phox knockout mice with disabled NADPH oxidase system, suggesting that NADPH oxidase-d…”
BackgroundCody, R. J., Haas, G. J., Binkley, P. F., Capers, Q., & Kelley, R. (1992) · Circulation · doi:10.1161/01.cir.85.2.504 · Cited by 647
Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death
Gami, A. S., Olson, E. J., Shen, W. K., Wright, R. S., Ballman, K. V., Hodge, D. O., Herges, R. M., Howard, D. E., & Somers, V. K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.080 · Cited by 620
Rho-Kinase Mediates Hypoxia-Induced Downregulation of Endothelial Nitric Oxide Synthase
Takemoto, M., Sun, J., Hiroki, J., Shimokawa, H., & Liao, J. K. (2002) · Circulation · doi:10.1161/01.cir.0000020682.73694.ab · Cited by 475
Frostell, C. G., Blomqvist, H., Hedenstierna, G., Lundberg, J., & Zapol, W. M. (1993) · Anesthesiology · doi:10.1097/00000542-199303000-00005 · Cited by 458
Prevention of High-Altitude Pulmonary Edema by Nifedipine
Bartsch, P., Maggiorini, M., Ritter, M., Noti, C., Vock, P., & Oelz, O. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251805 · Cited by 451
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
The Obesity-Hypoventilation Syndrome Revisited
Kessler, R., Chaouat, A., Schinkewitch, P., Faller, M., Casel, S., Krieger, J., & Weitzenblum, E. (2001) · Chest · doi:10.1378/chest.120.2.369 · Cited by 408
Signaling Molecules in Nonfamilial Pulmonary Hypertension
Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021650 · Cited by 400
Janda, S., Shahidi, N., Gin, K., & Swiston, J. (2011) · Heart · doi:10.1136/hrt.2010.212084 · Cited by 375
Yoshibayashi, M., Nishioka, K., Nakao, K., Saito, Y., Matsumura, M., Ueda, T., Temma, S., Shirakami, G., Imura, H., & Mikawa, H. (1991) · Circulation · doi:10.1161/01.cir.84.6.2280 · Cited by 332
Pulmonary Hemodynamics in the Obstructive Sleep Apnea Syndrome
Chaouat, A., Weitzenblum, E., Krieger, J., Oswald, M., & Kessler, R. (1996) · Chest · doi:10.1378/chest.109.2.380 · Cited by 321
Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure
Arias, M. A., García-Río, F., Alonso-Fernández, A., Martínez, I., & Villamor, J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi807 · Cited by 319 · cited 1×
“001).(85) CPAP therapy for 6–24 months improved right ventricular ejection fraction estimated by nuclear ventriculography, which increased from 30% 3% to 39% 3% (P 1⁄4 0.”
Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea
Møller, D. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03267-3 · Cited by 312
Obstructive sleep apnea as a risk factor for coronary events or cardiovascular death
Shah, N. A., Yaggi, H. K., Concato, J., & Mohsenin, V. (2010) · Sleep and Breathing · doi:10.1007/s11325-009-0298-7 · Cited by 298
Self-citationPulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort
Strange, G., Playford, D., Stewart, S., Deague, J. A., Nelson, H., Kent, A., & Gabbay, E. (2012) · Heart · doi:10.1136/heartjnl-2012-301992 · Cited by 296
Sleep-Disordered Breathing in Heart Failure with Normal Left Ventricular Ejection Fraction
Bitter, T., Faber, L., Hering, D., Langer, C., Horstkotte, D., & Oldenburg, O. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp057 · Cited by 292
Packer, M., McMurray, J., Massie, B. M., Caspi, A., Charlon, V., Cohen-Solal, A., Kiowski, W., Kostuk, W., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 275
The Influence of Hydrogen Ion Concentration and Hypoxia on the Pulmonary Circulation*
Enson, Y., Giuntini, C., Lewis, M. L., Morris, T. Q., Ferrer, M. I., & Harvey, R. M. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104999 · Cited by 268
Sajkov, D., Wang, T., Saunders, N. A., Bune, A. J., & Douglas Mcevoy, R. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.2010092 · Cited by 266 · cited 1×
“The reduction in mean Ppa was attributed to decreased pulmonary vascular resistance and decreased vasoconstrictive response to hypoxic stimulus.(84) In a randomized, sham-controlled crossover study involving 10 patients with OSA and PH (right ventricular systolic pressure [RVSP] >30 mmHg estimated by Doppler echocardi…”
BackgroundLeft ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea
Hedner, J., Ejnell, H., & Caidahl, K. (1990) · Journal of Hypertension · doi:10.1097/00004872-199010000-00009 · Cited by 250
MacLean, M. R., Herve, P., Eddahibi, S., & Adnot, S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703570 · Cited by 232
Pulmonary arterial hypertension in patients with sleep apnoea syndrome
Bady, E. (2000) · Thorax · doi:10.1136/thorax.55.11.934 · Cited by 226
Adiponectin Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular Remodeling
Medoff, B. D., Okamoto, Y., Leyton, P., Weng, M., Sandall, B. P., Raher, M. J., Kihara, S., Bloch, K. D., Libby, P., & Luster, A. D. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0415oc · Cited by 212
Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial Cells
Pichiule, P., Chavez, J. C., & LaManna, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305146200 · Cited by 210
Nocturnal Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
Boysen, P. G., Block, A. J., Wynne, J. W., Hunt, L. A., & Flick, M. R. (1979) · Chest · doi:10.1378/chest.76.5.536 · Cited by 207
Peled, N., Abinader, E. G., Pillar, G., Sharif, D., & Lavie, P. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00407-6 · Cited by 207
Obstructive Sleep Apnea and Pulmonary Hypertension
Sajkov, D., & McEvoy, R. D. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.06.001 · Cited by 196
Pulmonary Hypertension Associated with Left-Sided Heart Disease
Oudiz, R. J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2006.12.001 · Cited by 186
Pulmonary hypertension in healthy men born and living at high altitudes
Peñaloza, D., Sime, F., Banchero, N., Gamboa, R., Cruz, J., & Marticorena, E. (1963) · The American Journal of Cardiology · doi:10.1016/0002-9149(63)90055-9 · Cited by 180
Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension
Zhao, Y. D., Campbell, A. I. M., Robb, M., Ng, D., & Stewart, D. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070587.79937.f0 · Cited by 176
Reprint of “Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity”
Arita, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.08.024 · Cited by 173
Daytime Pulmonary Hypertension in Patients with Obstructive Sleep Apnea
Alchanatis, M., Tourkohoriti, G., Kakouros, S., Kosmas, E., Podaras, S., & Jordanoglou, J. B. (2001) · Respiration · doi:10.1159/000050574 · Cited by 169
The Role of NADPH Oxidase in Chronic Intermittent Hypoxia-Induced Pulmonary Hypertension in Mice
Nisbet, R. E., Graves, A. S., Kleinhenz, D. J., Rupnow, H. L., Reed, A. L., Fan, T.-H. M., Mitchell, P. O., Sutliff, R. L., & Hart, C. M. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/2008-0145oc · Cited by 167
Chami, H. A., Devereux, R. B., Gottdiener, J. S., Mehra, R., Roman, M. J., Benjamin, E. J., & Gottlieb, D. J. (2008) · Circulation · doi:10.1161/circulationaha.107.717892 · Cited by 161
Frequency and Impact of Pulmonary Hypertension in Patients With Obstructive Sleep Apnea Syndrome
Minai, O. A., Ricaurte, B., Kaw, R., Hammel, J., Mansour, M., McCarthy, K., Golish, J. A., & Stoller, J. K. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.06.048 · Cited by 156 · cited 2×
“Left ventricular dysfunction accounts for a large proportion of PH in patients with OSA.(17,22) However, PH and right heart failure can develop in patients with OSA with preserved left ventricular ejection fraction.”
BackgroundDaytime Pulmonary Hemodynamics in Patients with Obstructive Sleep Apnea without Lung Disease
SAJKOV, D., WANG, T., SAUNDERS, N. A., BUNE, A. J., NEILL, A. M., & McEVOY, R. D. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9805086 · Cited by 155
Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice
Campen, M. J., Shimoda, L. A., & O’Donnell, C. P. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00411.2005 · Cited by 154
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension
Egermayer, P., Town, G. I., & Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.2.161 · Cited by 124
Jilwan, F. N., Escourrou, P., Garcia, G., Jaïs, X., Humbert, M., & Roisman, G. (2013) · Chest · doi:10.1378/chest.11-3124 · Cited by 115 · cited 2×
“The prevalence of OSA in patients with PAH and chronic thromboembolic PH (CTEPH) with New York Heart Association functional class II–III without COPD or left ventricular dysfunction was 89%.(19) In a study of 169 patients with PAH, 45 patients (26.”
BackgroundSleep-Related Breathing Disorders in Patients With Pulmonary Hypertension
Ulrich, S., Fischler, M., Speich, R., & Bloch, K. E. (2008) · CHEST Journal · doi:10.1378/chest.07-3035 · Cited by 112
Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease
Summer, R., Fiack, C. A., Ikeda, Y., Sato, K., Dwyer, D., Ouchi, N., Fine, A., Farber, H. W., & Walsh, K. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90599.2008 · Cited by 112
Recapitulation of Developing Artery Muscularization in Pulmonary Hypertension
Sheikh, A. Q., Lighthouse, J. K., & Greif, D. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.042 · Cited by 111
Sforza, E., Krieger, J., Weitzenblum, E., Apprill, M., Lampert, E., & Ratamaharo, J. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.866 · Cited by 109
Kaluski, E., Cotter, G., Leitman, M., Milo‐Cotter, O., Krakover, R., Kobrin, I., Moriconi, T., Rainisio, M., Caspi, A., Reizin, L., et al. (2007) · Cardiology · doi:10.1159/000107791 · Cited by 106
Pulmonary hypertension in obesity-hypoventilation syndrome
Kauppert, C. A., Dvorak, I., Kollert, F., Heinemann, F., Jörres, R. A., Pfeifer, M. A., & Budweiser, S. (2011) · European Respiratory Journal · doi:10.1016/j.rmed.2013.09.017 · Cited by 97
Vatansever, E., Sürmen-Gür, E., Ursavaş, A., & Karadağ, M. (2010) · Sleep And Breathing · doi:10.1007/s11325-010-0378-8 · Cited by 95
McGuire, S., & Bradford, A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00078801 · Cited by 87
Sleep apnea in precapillary pulmonary hypertension
Dumitrascu, R., Tiede, H., Eckermann, J., Mayer, K., Reichenberger, F., Ghofrani, H. A., Seeger, W., HEITMANN, J., & Schulz, R. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.11.013 · Cited by 84
Endothelin Mediates Increased Pulmonary Vascular Tone in Patients With Heart Failure
Ooi, H., Colucci, W. S., & Givertz, M. M. (2002) · Circulation · doi:10.1161/01.cir.0000034444.31846.f4 · Cited by 83
Hypoxic upregulation of arginase II in human lung endothelial cells
Krotova, K., Patel, J. M., Block, E. R., & Zharikov, S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00068.2010 · Cited by 80
The role of hypoxia in pulmonary vascular diseases: a perspective
Voelkel, N. F., Mizuno, S., & Bogaard, H. J. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2012 · Cited by 75
Pulmonary Hemodynamics in the Obstructive Sleep Apnea Syndrome
Krieger, J., & Weitzenblum, E. (1991) · Springer eBooks · doi:10.1007/978-3-642-76034-1_42 · Cited by 68
The Role of Endothelium in Hypoxic Constriction of Human Pulmonary Artery Rings
Demiryürek, A. T., Wadsworth, R. M., Kane, K. A., & Peacock, A. J. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.2.283 · Cited by 67
Right ventricular hypertrophy in native children living at high altitude.
Arias‐Stella, J., & Recavarren, S. (1962) · PubMed · Cited by 67
Bergofsky, E. H., Haas, F., & Porcelli, R. J. (1969) · PubMed · Cited by 67
Wu, W., Platoshyn, O., Firth, A. L., & Yuan, J. X. ‐. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00203.2007 · Cited by 64
Kugathasan, L., Ray, J. B., Deng, Y., Rezaei, E., Dumont, D., & Stewart, D. J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090389 · Cited by 61
Wang, B., Yan, B., Song, D., Ye, X., & Liu, S. F. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.020 · Cited by 58
Burger, C. D., Foreman, A. J., Miller, D. P., Safford, R. E., McGoon, M. D., & Badesch, D. B. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0394 · Cited by 56
Beleslin‐Čokić, B. B., Čokić, V. P., Wang, L., Piknova, B., Teng, R., Schechter, A. N., & Noguchi, C. T. (2011) · Cytokine · doi:10.1016/j.cyto.2011.01.015 · Cited by 55
Nahmias, J., Lao, R., & Karetzky, M. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09050945 · Cited by 52
Hansdóttir, S., Groskreutz, D. J., & Gehlbach, B. K. (2013) · CHEST Journal · doi:10.1378/chest.12-2114 · Cited by 48
Segers, V. F. M., Brutsaert, D. L., & Keulenaer, G. W. D. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283512035 · Cited by 45
Effect of ‘unilateral hypoxia’; on pulmonary blood flow distribution in normal subjects
Defares, J. G., Lundin, G., Arborelius, M., Strömblad, R., & Svanberg, L. (1960) · Journal of Applied Physiology · doi:10.1152/jappl.1960.15.1.169 · Cited by 45
Clinical Perspective of Hypoxia-Mediated Pulmonary Hypertension
Preston, I. R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1587 · Cited by 44
Alveolar-Derived Exhaled Nitric Oxide Is Reduced in Obstructive Sleep Apnea Syndrome
Foresi, A., Leone, C., Olivieri, D., & Cremona, G. (2007) · CHEST Journal · doi:10.1378/chest.06-3124 · Cited by 44
Pulmonary Hemodynamics in Obstructive Sleep Apnea: Frequency and Causes of Pulmonary Hypertension
Hetzel, M., Kochs, M., Marx, N., Woehrle, H., Mobarak, I., Hombach, V., & Hetzel, J. (2003) · Lung · doi:10.1007/s00408-003-1017-y · Cited by 42
Influence of unilateral hypoxia on blood flow through the lungs in man in lateral position
Arborelius, M., Lundin, G., Svanberg, L., & Defares, J. G. (1960) · Journal of Applied Physiology · doi:10.1152/jappl.1960.15.4.595 · Cited by 35
Wang, Z., Li, A., Guo, Q., Zhang, J., An, Q., Guo, Y., Chu, L., Weiss, J. W., & Ji, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058078 · Cited by 34
Yu, L., Quinn, D. A., Garg, H. G., & Hales, C. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0145oc · Cited by 32
The protective role of adiponectin in pulmonary vascular disease
Hansmann, G., & Rabinovitch, M. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00367.2009 · Cited by 31
Schwappacher, R., Kilić, A., Kojonazarov, B. K., Lang, M., Diep, T., Zhuang, S., Gawlowski, T., SCHERMULY, R. T., Pfeifer, A., Boss, G. R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.458729 · Cited by 26
Circulating antiangiogenic proteins in obstructive sleep apnea and hypertension
Mohsenin, V., & Urbano, F. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.01.001 · Cited by 26
Self-citationJafari, B., & Mohsenin, V. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.56 · Cited by 17
Self-citationSerum levels of angiopoietin-1 in patients with pulmonary hypertension due to mitral stenosis
Karapınar, H., Esen, Ö., Emiroğlu, Y., Akçakoyun, M., Pala, S., Kargın, R., İzgi, A., Kırma, C., & Esen, A. M. (2010) · Heart and Vessels · doi:10.1007/s00380-010-0092-2 · Cited by 7
Cited by
Yeghiazarians, Y., Jneid, H., Tietjens, J. R., Redline, S., Brown, D. L., El-Sherif, N., Mehra, R., Bozkurt, B., Ndumele, C. E., Somers, V. K., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000988 · Cited by 1,431
Zoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Tietjens, J. R., Claman, D., Kezirian, E. J., De Marco, T., Mirzayan, A., Sadroonri, B., Goldberg, A. N., Long, C., Gerstenfeld, E. P., & Yeghiazarians, Y. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010440 · Cited by 397
“Signaling pathways implicated in hypoxic vasoconstriction in PH include nitric oxide, endothelin, angiopoietin-1, serotonin, and NADPH-oxidase.(64) Chronic hypoxia activates additional inflammatory pathways resulting in pulmonary vascular remodeling and, eventually, irreversible increases in pulmonary vascular resista…”
BackgroundSleep Disordered Breathing and Cardiovascular Disease
Cowie, M. R., Linz, D., Redline, S., Somers, V. K., & Simonds, A. K. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.048 · Cited by 311
Obstructive sleep apnea: personal, societal, public health, and legal implications
Morsy, N. E., Farrag, N. S., Zaki, N. F. W., Badawy, A. Y., Abdelhafez, S. A., El‐Gilany, A., shafey, M. M. E., Pandi-Perumal, S. R., Spence, D. W., & BaHammam, A. S. (2019) · Reviews on Environmental Health · doi:10.1515/reveh-2018-0068 · Cited by 155
“In one study a multivariate linear regression analysis with adjustment for age, sex, body mass index, and the AHI, AHI during NREM (AHINREM) compared to AHI during REM (AHIREM) was found to be considerably more closely linked to psychomotor vigilance test lapses than AHI during REM.”
BackgroundInfluential
Metadata
- Authors
- Kholdani, C., Fares, W. H., & Mohsenin, V.
- Affiliations
- Yale University (US)
- Corresponding author
- Mohsenin, Vahid
- Venue
- Pulmonary Circulation
- Publisher
- Wiley
- Published
- 2015-06
- Volume
- 5
- Issue
- 2
- Pages
- 220-227
- ISSN
- 2045-8932 (ISSN-L)
- 2045-8940
- PMC
- PMC4449234
- OpenAlex
- W2028630811
- Cited by
- 127
- References
- 89
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 11 · 2023: 15 · 2022: 17 · 2021: 9 · 2020: 12 · 2019: 10 · 2018: 9 · 2017: 6 · 2016: 10 · 2015: 1
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Pulmonary Circulation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Apelin-related biomedical research
- Keywords
- pulmonary hypertension, obstructive sleep apnea, intermittent hypoxia, pulmonary venous hypertension, hypoxic pulmonary vasoconstriction, vascular remodeling, pulmonary artery pressure, prognosis, undertreatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.